This thread is a continuation of the thread:
Previous threads:
4 Likes
37 Likes
Threads may change, but high-quality companies will always be talked about. 
46 Likes
Voxtur’s decline also seems to have stopped, and Oroco is practically skyrocketing! Is it time to buy these yet?
30 Likes
You know what? I started investing in early 2022 and my portfolio is in the red, but this Pölhex performance doesn’t faze me at all, because I’ve been a SaiPa supporter for 30 years already. Free mental coaching!
146 Likes
Yesterday was a nice color for a change, as everything in the portfolio was in the green, except for VW. But I’m sure this will turn to sorrow again.
2 Likes
There are people on Lehto’s buy side, but since 140,000 shares only cost 4,000€, even an average Joe could clear that out pretty quickly 
3 Likes
An acquaintance this summer: I guess the price of “the rings” (Nokian Tyres) is starting to be about right… for a long-term hold. I was a bit skeptical, but he made his own decision. As a bear, I remember saying back then that it would probably test the €7.70 levels at least. Well, he bought a six-figure sum… definitely for a long-term hold.
26 Likes
Konecranes’ stock price reaction was a bit of a surprise. Orders did fall short of forecasts, but record-high EBITA and revenue exceeded estimates. I think it will stabilize during the day.
3 Likes
14 Likes
NELL has already clearly broken through its Covid lows. Now hydrogen companies here and across the pond are really being driven into the ground 
19 Likes
Still. I must be a fool, as I don’t understand why some people are buying this at these prices. I’ve been wondering about the same thing for a long time. The risks were absolutely horrific even before the latest news, and yet the share price just kept chugging upward and there were plenty of buyers. This year, it went into the red for the first time in the last days of August. It’s hard to make sense of that.
It’s that “a recession is coming any moment and credit losses will spiral out of control” pricing. By the time this materializes, the share price will already be at completely different levels. That’s just how bank stocks work. At the moment, buying is a vote for the idea that a recession won’t happen and credit losses won’t occur.
9 Likes
Herantis Pharma is seeing a nice lift after the release of positive results, just ten percent more and I’ll be at break-even (at the time of writing +25.00%) 
Edit: A rather mild price reaction to good news (at the time of writing +17.21%), at least compared to my own expectations, but maybe that’s exactly why the price isn’t rising—my expectations were too high, and I’ve been foolishly buying this since three euros in an averaging-down tragedy… that’s what you get for being a dart-throwing monkey 
4 Likes
This actually materialized sooner than I thought. Unfortunately, the plan to get back on board is a bit of a work in progress, as work is getting in the way of my hobbies.
Probably the first time ever that luck was on my side with the timing.
4 Likes
It looks like there are no more technical analysis support levels on the downside, except for zero, of course.
3 Likes